Rapid Paracetamol Test

About Fepod

Fepod is a privately-held, pre-revenue diagnostics company founded in 2017 and based in Helsinki, Finland, with a mission to transform acute care diagnostics. Its core innovation is a portable, fingerprick-based electrochemical platform that aims to provide lab-quality results at the patient's side within minutes, enabling faster clinical decisions. Backed by lead investor Almaral Oy and accepted into the Mayo Clinic Innovation Exchange, Fepod is advancing its first paracetamol test through clinical validation and regulatory steps, targeting a global leadership position in acute care POC diagnostics by 2030.

Therapeutic Areas